Personal Genome Diagnostics, Five Prime Therapeutics to develop bemarituzumab companion diagnostic April 4, 2018
CARB-X collaborates with Helixbind to support development of RaPID/BSI diagnostic test March 16, 2018
FUJIFILM RI Pharma begins phase II studies of F-1641 for refractory pheochromocytoma in Japan Feb. 20, 2018
FDA grants de novo request for commercialization of Banyan BTI test for traumatic brain injury Feb. 15, 2018
Cancer Targeted Technology, Advanced Accelerator Applications enter CTT-1057 license agreement Feb. 13, 2018
RSS